| The target landscape of clinical kinase drugs S Klaeger, S Heinzlmeir, M Wilhelm, H Polzer, B Vick, PA Koenig, ... Science 358 (6367), eaan4368, 2017 | 847 | 2017 |
| A deep proteome and transcriptome abundance atlas of 29 healthy human tissues D Wang, B Eraslan, T Wieland, B Hallström, T Hopf, DP Zolg, J Zecha, ... Molecular systems biology 15 (2), e8503, 2019 | 699 | 2019 |
| TMT Labeling for the Masses: A Robust and Cost-efficient, In-solution Labeling Approach J Zecha, S Satpathy, T Kanashova, SC Avanessian, MH Kane, ... Molecular & cellular proteomics 18 (7), 1468-1478, 2019 | 371 | 2019 |
| Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC–MS/MS Y Bian, R Zheng, FP Bayer, C Wong, YC Chang, C Meng, DP Zolg, ... Nature communications 11 (1), 157, 2020 | 343 | 2020 |
| Meltome atlas—thermal proteome stability across the tree of life A Jarzab, N Kurzawa, T Hopf, M Moerch, J Zecha, N Leijten, Y Bian, ... Nature methods 17 (5), 495-503, 2020 | 235 | 2020 |
| ProteomicsDB: a multi-omics and multi-organism resource for life science research P Samaras, T Schmidt, M Frejno, S Gessulat, M Reinecke, A Jarzab, ... Nucleic acids research 48 (D1), D1153-D1163, 2020 | 209 | 2020 |
| Peptide level turnover measurements enable the study of proteoform dynamics J Zecha, C Meng, DP Zolg, P Samaras, M Wilhelm, B Kuster Molecular & Cellular Proteomics 17 (5), 974-992, 2018 | 128 | 2018 |
| Lapatinib resistance in breast cancer cells is accompanied by phosphorylation-mediated reprogramming of glycolysis B Ruprecht, EA Zaal, J Zecha, W Wu, CR Berkers, B Kuster, S Lemeer Cancer research 77 (8), 1842-1853, 2017 | 112 | 2017 |
| Data, reagents, assays and merits of proteomics for SARS-CoV-2 research and testing J Zecha, CY Lee, FP Bayer, C Meng, V Grass, J Zerweck, K Schnatbaum, ... Molecular & Cellular Proteomics 19 (9), 1503-1522, 2020 | 99 | 2020 |
| Proteome activity landscapes of tumor cell lines determine drug responses M Frejno, C Meng, B Ruprecht, T Oellerich, S Scheich, K Kleigrewe, ... Nature communications 11 (1), 3639, 2020 | 72 | 2020 |
| Linking post-translational modifications and protein turnover by site-resolved protein turnover profiling J Zecha, W Gabriel, R Spallek, YC Chang, J Mergner, M Wilhelm, ... Nature communications 13 (1), 165, 2022 | 62 | 2022 |
| Decrypting drug actions and protein modifications by dose-and time-resolved proteomics J Zecha, FP Bayer, S Wiechmann, J Woortman, N Berner, J Müller, ... Science 380 (6640), 93-101, 2023 | 59 | 2023 |
| High pH reversed-phase micro-columns for simple, sensitive, and efficient fractionation of proteome and (TMT labeled) phosphoproteome digests B Ruprecht, J Zecha, DP Zolg, B Kuster Proteomics: Methods and Protocols, 83-98, 2017 | 51 | 2017 |
| The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma M Heider, R Eichner, J Stroh, V Morath, A Kuisl, J Zecha, J Lawatscheck, ... Molecular cell 81 (6), 1170-1186. e10, 2021 | 48 | 2021 |
| PTPN2 deficiency enhances programmed T cell expansion and survival capacity of activated T cells M Flosbach, SG Oberle, S Scherer, J Zecha, M von Hoesslin, F Wiede, ... Cell reports 32 (4), 2020 | 45 | 2020 |
| Evaluation of kinase activity profiling using chemical proteomics B Ruprecht, J Zecha, S Heinzlmeir, G Medard, S Lemeer, B Kuster ACS chemical biology 10 (12), 2743-2752, 2015 | 43 | 2015 |
| A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines FJ Ryan, TS Norton, C McCafferty, SJ Blake, NE Stevens, J James, ... Cell Reports Medicine 4 (3), 2023 | 30 | 2023 |
| The OTUD6B‐LIN28B‐MYC axis determines the proliferative state in multiple myeloma C Paulmann, R Spallek, O Karpiuk, M Heider, I Schäffer, J Zecha, ... The EMBO Journal 41 (20), e110871, 2022 | 15 | 2022 |
| Functional expression of electrogenic sodium bicarbonate cotransporter 1 (NBCe1) in mouse cortical astrocytes is dependent on S255‐257 and regulated by mTOR S Khakipoor, M Giannaki, SM Theparambil, J Zecha, B Küster, ... Glia 67 (12), 2264-2278, 2019 | 13 | 2019 |
| Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics YC Chang, C Gnann, RR Steimbach, FP Bayer, S Lechner, A Sakhteman, ... Cell reports 43 (6), 2024 | 6 | 2024 |
Bernhard KusterTechnical University of MunichEmail yang diverifikasi di tum.de